Principal Scientist, Biotransformation and Bioanalysis

City TherapeuticsCambridge, MassachusettsOn-siteFull-timePrincipal, 12–15+ yearsListed 11 minutes ago

Apply now

About this role

Principal Scientist, Biotransformation and Bioanalysis

Principal Scientist, Biotransformation and Bioanalysis

City Therapeutics is a biopharmaceutical company harnessing next-generation engineering to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas. Co-founded by pioneering executives and scientists in RNAi, City Therapeutics is based in Cambridge, MA, and has raised $140 million from leading life sciences investors.

We are seeking a Principal Scientist with expertise in LC-MS bioanalysis and biotransformation to join the Bioanalytical and Biomarker Sciences (BBS) team. Reporting to the Head of Bioanalytical and Biomarker Sciences (BBS), this role will support drug metabolism and pharmacokinetics (DMPK) studies of siRNA, including antibody- and peptide-conjugated siRNAs. This hands-on scientific leader will develop quantitative LC-MS/MS and high-resolution mass spectrometry (LC-HRMS) approaches to characterize drug exposure, tissue distribution, stability, and metabolism from discovery through IND/CTA-enabling studies and clinical development.

The successful candidate will lead internal and outsourced bioanalytical activities, partner with clinical pharmacology and pharmacokinetics, chemistry, and biology teams, and translate metabolism and analytical findings into information supporting candidate selection and development decisions.

Key Responsibilities

- Lead bioanalytical strategies for siRNA and conjugates, defining analytes and assay specificity for parent drug, individual strands, and metabolites in plasma, tissues, and other biological matrices.

- Develop, qualify, validate, and transfer quantitative LC-MS/MS methods for nonclinical and clinical studies. Optimize extraction, chromatography, internal standards, recovery, matrix effects, carryover, and analyte stability.

- Design and execute in vitro biotransformation studies and analyze in vivo samples using LC-HRMS/MS to characterize siRNA metabolites, conjugate catabolites, and linker or ligand degradation. Compare profiles across species and matrices.

- Develop or apply relevant in vitro models to evaluate siRNA and conjugate stability.

- Define bioanalytical strategies for intact antibody-oligonucleotide conjugates (AOCs) and peptide conjugates, conjugated siRNA and its relevant metabolites. Integrate immunocapture LC-MS and orthogonal assays, as appropriate.

- Provide bioanalytical support for PK-led drug distribution and disposition studies. Partner with PK scientists to interpret parent drug/metabolite exposure in relation to PK/PD, safety, and candidate selection.

- Represent BBS on project teams; advise on study design, sampling, assay sensitivity, and data interpretation to guide siRNA chemistry, conjugate optimization, and development decisions.

- Lead scientific oversight of bioanalytical CRO activities, including CRO selection, scope of works (SOWs), protocols, budgets, timelines, method transfer, data review, troubleshooting, and report finalization. Ensure deliverables meet scientific and program requirements.

- Establish fit-for-purpose method qualification or regulated validation requirements according to study purpose. Ensure compliance with applicable guidance, SOPs, protocols, and data integrity and lead analytical investigations.

- Prepare and review technical reports, SOPs, bioanalytical summaries, and IND/CTA submission contributions. Communicate findings, assay limitations, and recommendations clearly to scientific and program stakeholders.

- Mentor scientists and strengthen LC-MS capabilities for oligonucleotides and conjugates. Evaluate new technologies, improve workflows, oversee instrument performance and troubleshoot internal and external bioanalytical works.

Qualifications

- PH.D. in Analytical Chemistry, Pharmaceutical Sciences, Biochemistry, Oligo-Chemistry, or a related field, with 7+ years of relevant industry experience; candidates with an M.S. and 10+ years of directly relevant experience will also be considered.

- Extensive hands-on expertise in quantitative LC-MS/MS bioanalysis and LC-HRMS metabolite identification, including method development, sample preparation, instrument troubleshooting, and critical review of mass spectrometric data.

- Demonstrated experience with oligonucleotide bioanalysis and biotransformation, including metabolite profiling, structural assignment using accurate mass and MS/MS, and interpretation of in vitro and in vivo findings.

- Strong understanding of DMPK/ADME principles and their application to oligonucleotides and conjugated therapeutics, including nuclease-mediated metabolism, tissue disposition, conjugate stability, and PK/PD relationships.

- Experience qualifying and validating bioanalytical methods and supporting nonclinical or clinical studies, with sound judgment in setting assay requirements and managing data quality and sample stability.

- Proven ability to lead scientific activities independently, manage CRO partnerships, mentor colleagues, and prioritize multiple programs in a collaborative biotechnology environment.

- Excellent analytical, problem-solving, technical writing, and communication skills, with the ability to translate complex bioanalytical results into clear recommendations for cross-functional teams.

Preferred Qualifications

- Direct experience with siRNA therapeutics, including GalNAc conjugates, AOCs, or peptide-conjugated siRNA, and characterization of conjugate catabolism and payload release.

- Experience with hybridization-capture or immunocapture LC-MS, protein/peptide mass spectrometry, and complementary assays that distinguish intact, conjugated, total, and released drug species.

- Experience measuring intracellular or pharmacologically relevant siRNA species, including RISC-loaded guide strand, or working with tissue and subcellular fractions.

- Experience supporting IND/CTA-enabling and early clinical programs, contributing to regulatory submissions, and implementing data analysis or automation tools for LC-MS workflows.

Compensation
The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package. Pay range is $165,00 to $185,000.

City Therapeutics is an Equal Opportunity and Affirmative Action employer. All qualified applicants will receive consideration without regard to race, color, religion, national origin, gender, gender identity or expression, sexual orientation, age, disability, veteran status, or any other characteristic protected by law.

Please note this role is required to be on-site at our offices in Cambridge, MA 5 days a week.

City Therapeutics is accepting applications from direct candidates only. Agency inquiries or submissions will not be accepted at this time.